1588-A4

CAS No. 1698027-20-1

1588-A4( ARS-1620 Intermediate )

Catalog No. M22695 CAS No. 1698027-20-1

1588-A4 is an intermediate of ARS-1620 which is an atropisomeric selective KRASG12C inhibitor with desirable pharmacokinetics.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 239 In Stock
10MG 349 In Stock
25MG 583 In Stock
50MG 833 In Stock
100MG 1134 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    1588-A4
  • Note
    Research use only, not for human use.
  • Brief Description
    1588-A4 is an intermediate of ARS-1620 which is an atropisomeric selective KRASG12C inhibitor with desirable pharmacokinetics.
  • Description
    1588-A4 is an intermediate of ARS-1620 which is an atropisomeric selective KRASG12C inhibitor with desirable pharmacokinetics.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ARS-1620 Intermediate
  • Pathway
    MAPK/ERK Signaling
  • Target
    Ras
  • Recptor
    KRAS G12C
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1698027-20-1
  • Formula Weight
    445.7
  • Molecular Formula
    C17H19BrClFN4O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)(C)OC(=O)N1CCN(CC1)c1ncnc2c(F)c(Br)c(Cl)cc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • KRAS inhibitor C6ME

    KRAS inhibitor C6ME is a small-molecule compound that blocks biochemical and cellular functions of KRASG12V in vitro.

  • K-Ras G12C-IN-3

    A novel and irreversible inhibitor of mutant K-ras G12C.

  • MRTX849

    MRTX849 is a potent selective and covalent KRASG12C inhibitor with potential antineoplastic activity.selectively modifies mutant cysteine 12 in GDP-bound KRASG12C and inhibits KRAS-dependent signaling.